Residency Publications
Corey, Kristin M., Lyra B. Olson, Ibtehaj A. Naqvi, Sarah A. Morrison, Connor Davis, Shahid M. Nimjee, Loretta G. Que, et al. “Suppression of Fibrinolysis and Hypercoagulability, Severity of Hypoxemia, and Mortality in COVID-19 Patients: A Retrospective Cohort Study.” Anesthesiology 137, no. 1 (July 1, 2022): 67–78. https://doi.org/10.1097/ALN.0000000000004239.
Pierce, Jacob B., Robert J. Mentz, Jie-Lena Sun, Brooke Alhanti, David J. Whellan, William E. Kraus, Ileana L. Piña, Mona Fiuzat, Christopher M. O’Connor, and Stephen J. Greene. “Titration of medical therapy and clinical outcomes among patients with heart failure with reduced ejection fraction: Findings from the HF-ACTION trial.” Am Heart J 251 (May 29, 2022): 115–26. https://doi.org/10.1016/j.ahj.2022.05.018.
Townsend, Matthew J., Mechelle D. Claridy, Simar S. Bajaj, Lucy Tu, and Fatima C. Stanford. “Obesity and Eligibility for Obesity Treatments Among Adults With Disabilities in the U.S.” American Journal of Preventive Medicine, May 22, 2022, S0749-3797(22)00217-3. https://doi.org/10.1016/j.amepre.2022.04.003.
Slauer, Ryan D., Ahmad Mourad, Govind Krishnan, and Colby Feeney. “Mycoplasma pneumoniae-associated diffuse alveolar haemorrhage: an atypical presentation of a prevalent pathogen.” Bmj Case Rep 15, no. 4 (April 29, 2022). https://doi.org/10.1136/bcr-2021-248273.
Townsend, Matthew J., Niyoti Reddy, and Fatima C. Stanford. “Geography and equity: expanding access to obesity medicine diplomate care.” International Journal of Obesity (2005) 46, no. 3 (March 2022): 447–48. https://doi.org/10.1038/s41366-021-01044-5.
Zhang, Audrey D., Jeremy Puthumana, Alexander C. Egilman, Jason L. Schwartz, and Joseph S. Ross. “Demographic Characteristics of Participants in Trials Essential to US Food and Drug Administration Vaccine Approvals, 2010-2020.” Journal of General Internal Medicine 37, no. 3 (February 2022): 700–702. https://doi.org/10.1007/s11606-021-06670-3.
Wolf, Monroe A., Nathan M. Thielman, and Bryan D. Kraft. “Treatment of Acanthamoeba Encephalitis.” Am J Med 135, no. 1 (January 2022): e20–21. https://doi.org/10.1016/j.amjmed.2021.08.009.
Pierce, Jacob B., Haoyang Zhou, Viorel Simion, and Mark W. Feinberg. “Long Noncoding RNAs as Therapeutic Targets.” In Long Noncoding RNA, 161–75. Springer International Publishing, 2022. https://doi.org/10.1007/978-3-030-92034-0_9.
Doucette, Kimberley, Mary‐Elizabeth Percival, Lacey Williams, Adrese Kandahari, Allison Taylor, Shuqi Wang, Jaeil Ahn, Judith E. Karp, and Catherine Lai. “Hypoalbuminemia as a prognostic biomarker for higher mortality and treatment complications in acute myeloid leukemia.” Hematological Oncology 39, no. 5 (December 2021): 697–706. https://doi.org/10.1002/hon.2925.
Rubin, E. B., J. A. Boiarsky, L. A. Canha, A. Giobbie-Hurder, M. Liu, M. J. Townsend, and M. Dougan. “Bamlanivimab Efficacy in Older and High-BMI Outpatients with COVID-19 Selected for Treatment in a Lottery-Based Allocation Process.” Open Forum Infectious Diseases 8, no. 12 (December 1, 2021). https://doi.org/10.1093/ofid/ofab546.